Interestingly, PI3KCA mutations, such as H1047R, demonstrate an abnormal sensitivity to mTOR/PI3K inhibitor BEZ-235 and a subsequent decrease in cell growth in HPV-positive HNC tumor graft models [143]. Here, PIK3CA is linked to neoplasm.